ESTA ESTABLISHMENT LABS HOLDINGS INC.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1688757 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY38.3%
TTM net income YoY53.7%
TTM EPS YoY55.3%
Revenue 3-yr CAGR14.2%
Net income 3-yr CAGR—
Margins
Gross margin70.2%
Operating margin-6.6%
Net margin-14.6%
FCF margin-8.2%
EBITDA margin—
Returns
ROE-240.7%
ROA-11.0%
ROIC (approx.)-6.7%
Asset turnover0.76x
Leverage & solvency
Liabilities / assets95.7%
Debt / equity17.17x
Current ratio3.57x
Interest coverage-0.62x
Cash quality & payout
Operating cash flow / net income0.35x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue3.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $211.08M | $166.03M | $165.15M | $161.70M | $126.68M |
| Cost of revenue | $64.77M | $56.50M | $58.17M | $55.10M | $41.28M |
| Gross profit | $146.31M | $109.53M | $106.98M | $106.59M | $85.40M |
| R&D expense | $20.25M | $19.71M | $26.43M | $20.27M | $18.32M |
| SG&A expense | $165.07M | $139.81M | $145.57M | $125.98M | $92.23M |
| Operating income | -$39.01M | -$49.99M | -$65.03M | -$39.66M | -$25.14M |
| Interest expense | $25.26M | $20.83M | $15.39M | $11.76M | $9.06M |
| Pretax income | -$58.02M | -$84.63M | -$78.58M | -$72.82M | -$39.71M |
| Income tax | -$6.96M | -$32,000 | -$81,000 | $2.38M | $1.43M |
| Net income | -$51.06M | -$84.60M | -$78.50M | -$75.21M | -$41.14M |
| EBITDA | -$32.81M | -$45.29M | -$62.23M | -$37.16M | -$22.64M |
| EPS (basic) | -1.72 | -3.00 | -3.07 | -3.08 | -1.72 |
| EPS (diluted) | -1.72 | -3.00 | -3.07 | -3.08 | -1.72 |
| Weighted avg. shares (diluted) | 29.62M | 28.16M | 25.60M | 24.46M | 23.97M |
| Balance sheet | |||||
| Cash & equivalents | $75.57M | $90.35M | $40.03M | $66.36M | $53.41M |
| Receivables | $77.50M | $65.00M | $46.92M | $35.42M | $24.44M |
| Inventory | $85.61M | $78.77M | $79.47M | $36.58M | $28.41M |
| Current assets | $249.94M | $243.04M | $174.90M | $149.90M | $113.27M |
| PP&E, net | $75.61M | $78.03M | $77.20M | $51.09M | $18.66M |
| Goodwill | $1.21M | $1.21M | $465,000 | $465,000 | $465,000 |
| Intangibles | $9.94M | $11.68M | $7.99M | $4.61M | $4.37M |
| Total assets | $357.17M | $346.83M | $268.64M | $211.06M | $139.53M |
| Current liabilities | $82.14M | $68.28M | $57.15M | $38.96M | $31.89M |
| Short-term debt | — | $0 | — | — | — |
| Long-term debt | $247.52M | $219.58M | $188.74M | $175.46M | $51.91M |
| Total debt | $247.52M | $219.58M | $188.74M | $175.46M | $51.91M |
| Total liabilities | $333.62M | $293.74M | $250.25M | $219.25M | $88.79M |
| Shareholders' equity | $23.55M | $53.09M | $18.39M | -$8.19M | $50.74M |
| Net debt | $171.95M | $129.23M | $148.70M | $109.11M | -$1.51M |
| Shares outstanding | 29.30M | 28.79M | 26.09M | 24.41M | 24.08M |
| Cash flow statement | |||||
| Operating cash flow | -$50.89M | -$58.52M | -$88.51M | -$52.17M | -$27.53M |
| Capital expenditure | $6.05M | $6.11M | $7.91M | $2.85M | $2.42M |
| Free cash flow | -$56.94M | -$64.63M | -$96.42M | -$55.02M | -$29.96M |
| Investing cash flow | -$7.03M | -$15.61M | -$24.55M | -$34.79M | -$7.16M |
| Financing cash flow | $40.43M | $125.89M | $86.23M | $100.25M | $4.05M |
| Depreciation & amortization | $6.20M | $4.70M | $2.80M | $2.50M | $2.50M |
| Stock-based compensation | $11.41M | $14.40M | $14.36M | $13.36M | $10.41M |
Free plan shows the latest 5 periods; Pro shows all 9 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.